These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10643493)

  • 21. Antibiotic overuse and resistance in dermatology.
    Chon SY; Doan HQ; Mays RM; Singh SM; Gordon RA; Tyring SK
    Dermatol Ther; 2012; 25(1):55-69. PubMed ID: 22591499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of psoriasis.
    Amann LP
    Nursing (Lond); 1981 Jun; 1(26):1119-22. PubMed ID: 6965151
    [No Abstract]   [Full Text] [Related]  

  • 23. [Topical treatments for psoriasis in 2009].
    Thielen AM; Laffitte E
    Rev Med Suisse; 2009 Apr; 5(200):876, 878-81. PubMed ID: 19438087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of psoriasis-arthritis and psoriasis vulgaris with infliximab].
    Mrowietz U; Barth J; Boehncke WH; Reich K; Rosenbach T; Streit V; Wozel G
    J Dtsch Dermatol Ges; 2006 May; 4(5):444-7. PubMed ID: 16686615
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of infliximab in the treatment of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
    Adişen E; Karaca F; Oztaş M; Gürer MA
    Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
    [No Abstract]   [Full Text] [Related]  

  • 29. Folate with methotrexate: big benefit, questionable cost.
    Brownell I; Strober BE
    Br J Dermatol; 2007 Jul; 157(1):213. PubMed ID: 17578449
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse events from systemic therapies for psoriasis are common in clinical practice.
    Pearce DJ; Higgins KB; Stealey KH; Balkrishnan R; Crane MM; Camacho F; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2006; 17(5):288-93. PubMed ID: 17092859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bath-PUVA therapy induces circulating regulatory T cells in patients with psoriasis.
    Saito C; Maeda A; Morita A
    J Dermatol Sci; 2009 Mar; 53(3):231-3. PubMed ID: 19070466
    [No Abstract]   [Full Text] [Related]  

  • 32. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine therapy in dermatology.
    Mrowietz U; Klein CE; Reich K; Rosenbach T; Ruzicka T; Sebastian M; Werfel T
    J Dtsch Dermatol Ges; 2009 May; 7(5):474-9. PubMed ID: 19302564
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment goals in psoriasis.
    Reich K; Mrowietz U
    J Dtsch Dermatol Ges; 2007 Jul; 5(7):566-74. PubMed ID: 17610606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Working group of Dermatologic Oncology ADO. Second-line therapy in stage IV melanoma].
    J Dtsch Dermatol Ges; 2007 Oct; 5(10):959. PubMed ID: 17910683
    [No Abstract]   [Full Text] [Related]  

  • 36. Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions.
    Opmeer BC; Heydendael VM; deBorgie CA; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
    J Clin Epidemiol; 2007 Jul; 60(7):696-703. PubMed ID: 17573985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Methotrexate].
    Beylot-Barry M; Le Maitre M
    Ann Dermatol Venereol; 2011 Dec; 138(12):833-5. PubMed ID: 22137621
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate for psoriasis: current European practice. A postal survey.
    Boffa MJ
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists.
    Patel V; Horn EJ; Lobosco SJ; Fox KM; Stevens SR; Lebwohl M
    J Am Acad Dermatol; 2008 Jun; 58(6):964-9. PubMed ID: 18378352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.